Generation of T-cell lines to autologous acute myeloid leukemia cells by competitive limiting dilution culture of acute myeloid leukemia mononuclear cells

Experimental Hematology

Volumn 36, Issue 4, 2008, Pages 486-494

  Zhong, Rui Kun ^a   Lane, Thomas A ^a   Ball, Edward D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2;

ACUTE GRANULOCYTIC LEUKEMIA; ADOPTIVE TRANSFER; ARTICLE; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LYMPHOBLASTOID CELL; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKEMIA, MYELOID, ACUTE; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS;

EID: 40649118940     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.11.012     Document Type: Article

References (20)

1. Scheibenbogen C., Letsch A., Thiel E., et al. CD8 T-cell responses to Wilms tumor gene product WT1 and proteinase 3 in patients with acute myeloid leukemia. Blood 15 100 (2002) 2132-2137
2. Inoue K., Ogawa H., and Sonoda Y. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89 (1997) 1405-1412
3. Greiner J., Li L., Ringhoffer M., et al. Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemia. Blood 106 (2005) 938-945
4. Andersen M.H., Svane I.M., Kvistborg P., et al. Immunogenicity of Bcl-2 in patients with cancer. Blood 105 (2005) 728-734
5. Brossart P., Schneider A., Dill P., et al. The epithelial tumor antigen MUC1 is expressed in hematological malignancies and is recognized by MUC1-specific cytotoxic T-lymphocytes. Cancer Res 61 (2001) 6846-6850
6. Callan M.F.C., Tan L., Annels N., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 187 (1998) 1395-1402
7. Hislop A.D., Annels N.E., Gudgeon N.H., et al. Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 195 (2002) 893-905
8. Zhong R.K., Rassenti L.Z., Kipps T.J., et al. Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia. Biol Blood Marrow Transplant 8 (2002) 557-556
9. Zhong R.K., Lane T.A., Ball E.D., et al. CTLA-4 blockade by a human monoclonal antibody MDX-010 enhances the capacity of AML-derived dendritic cells to induce T cell responses against AML cells in an autologous culture system. Cytotherapy 8 (2006) 3-12
10. Fazekas de St Groth S. The evaluation of limiting dilution assays. J Immunol Methods 49 (1982) R11
11. Zhong R.K., Astle C.M., and Harrison D.E. Distinct developmental patterns of short-term and long-term functioning lymphoid and myeloid precursors defined by competitive limiting dilution analysis in vivo. J Immunol 157 (1996) 138-145
12. Zhong R.K., Donnenberg A.D., and Ball E.D. Differential effect of 4-HC and antimyeloid monoclonal antibodies on T and natural killer cells during bone marrow purging. Blood 83 (1994) 2345-2351
13. Choudhury B.A., Liang J.C., Thomas E.K., et al. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93 (1999) 780-786
14. Charbonnier A., Gaugler B., Sainty D., et al. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol 29 (1999) 2567-2578
15. Harrison B.D., Aams J.A., Briggs M., et al. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia. Blood 97 (2001) 2764-2771
16. Assudani D.P., Horton R.B., Mathieu M.G., et al. The role of CD4+ T cell help in cancer immunity and the formulation of novel cancer vaccines. [review]. Cancer Immunol Immunother 56 (2007) 70-80
17. Antony P.A., Piccirillo C.A., Akpinarli A., et al. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 174 (2005) 2591-2601
18. Gerloni M., and Zanetti M. CD4 T cells in tumor immunity. [review]. Springer Semin Immunopathol 27 (2005) 37-48
19. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. [review]. Nature 411 6835 (2001) 380-384
20. Hanson C.A., Gajl-Peczalska K.J., Parkin J.L., et al. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique. Blood 70 (1987) 83-89